A Review- Nanogel Drug Delivery System
Saurabh Tiwari*, Shweta Singh, Dr. Pushpendra
Kumar Tripathi, Mr. Chetan
Kumar Dubey
Rameshwaram Institute of Technology and
Managemnt, Lucknow, U.P
*Corresponding Author E-mail: tiwari.saurabh252@gmail.com
Nanogels are one of the techniques in nanotechnology which has been most popular
in effective drug delivery inside the body as well as topical treatment.
Certain properties of nanogels make them suitable to
carry different types of molecules like DNA, proteins, oligonucleotides,
RNA, dyes, quantum dots and certain chemical agents like diclofenac
to the target site. Its nano-sized structure has showed
the reduced effect of toxicity of drug molecule as well as it provides
controlled release of drug at the target site, increased the bioavailability of
the drug. Besides it, nanogels have increased the
life span of drugs in the body to enhance its effective results for the
treatment of desired disease.
KEYWORDS: Nanogels, diclofenac, nanotechnology, topical
treatment.
INTRODUCTION:
Nanotechnology, a relatively novel
technique, offers a broad scope for a smart drug delivery and drug
manufacturing (nanomedicine) approach involving the
design, synthesis and characterization of materials or molecules and devices
that have effective function at nanometer scale. This technique mainly focuses
on the radiacal improvements in the current
therapeutic and diagnostic procedures. Development of novel nano-sized
particulate drug delivery systems (DDS) have shown the profound impact on
disease prevention, diagnosis, and treatment as reported after the researches
in academic laboratories and pharmaceutical companies all over the world. This
technique have overcome the challenges by enhancing absorption of drugs,
reducing toxicity of drugs, controlled release of doses and reducing
biodegradation. It has also reduces the chances of activation of immune cells
upon administration of drugs inside the body.
Various nanotechnological
techniques like protein based nanoparticles, lipid
based nanoparticles, nanoemulsions,
nanocrystals, nanodiamonds,
carbon nanotubes, nanosuspensions
and nanogels have been introduced as an advanced DDS
in which nanogels have been introduced in the market
due to its maximum advantages over other DDS techniques (2)(5)(6). Nanogels (nanosized hydrogels) are physically or chemically cross-linked,
swollen small particles which are made up of flexible hydrophilic or amphiphilic polymer networks. These polymer networks can be
anionic or ionic. They behaves as a carrier molecule for drugs and designed in
which a way that they can easily absorb biologically active compounds by the
formation of biomolecular interactions like salt
bonds, hydrophobic or hydrogen bonding. They are designed in such a way that
these nanogels can easily encapsulate diverse class
of biomolecules by optimizing the molecular
composition, size and morphology, to ensure the controlled release of drug
molecule in vivo. When nanogels dispersed in the aqueous media, their swollen
networks become soft and are able to encapsulate a required volume of water.
Fig. 1: Model showing releasing of Drug from Nanogel
Desired biological or drug molecules can
be loaded into the nanogels by allowing the formation
of spontaneous interactions between the polymer matrix and the agents;
resulting in the formation of highly dispersed hydrophilic particles. This
resulting structure is able to provide physical protection to the desired
loaded biomolecule from degradation. Therefore, nanogels are a kind of versatile structure for both drug
encapsulation and drug controlled release on the target site (3) (5) (7) (8).
Nanogels, during the first decade of its development, have
been proved to be a potential structure for systemic drug release, designing of
multifunctional nanocarriers like theranostics
and controlled drug release at the target site.
Due to the large surface area and
adjustable sixe of nanogels, these molecules are able
to incorporate different molecules.
Table 1: Types of nanogels
and polymers used in the treatment of diseases
Polymer |
Type of Nanogel |
Acetylated chondroitin
sulfate |
Self organizing nanogel |
Cross linked polyethyleneimine
and PEG/pluronic |
Biodegradable nanogel |
Glycol chitosan grafted with
3-diethylaminopropyl groups |
pH-responsive |
Pullulan/folate-pheophorbide |
Self quenching polysaccharide based |
Crosslinked branched network of polyethyleneimine
and PEG |
Polyplex nanogel |
Polyethyleneimine nanogels |
Size dependent property nanogel |
Cholesterol bearing pullulan
nanogels |
Sustained release nanogel |
Reducible heparin with disulfide linkage |
Reducible nanogel |
Pluronic polyethyleneimine/DNA
complex |
Temperature responsive and volume transition nanogels |
Acetylated hylauronic acid |
Specific targeting nanogel |
Polyacrylamide |
Novel core shell magnetic nanogel |
Reference:
Sultana et al. / Journal of Applied Pharmaceutical Science 3 (8 Suppl 1); 2013: S95-S105
According to the researches it has been
observed that drugs involving DNA/RNA and inorganic molecules are incorporate
in cases of delivering drugs at the site of brain. Molecules like polyethyleneglycol (PEG) and polyethylenimine
when embedded in a nanogel has been proved that this
composition is able to cross the blood-brain barrier and deliver oligonucleotides to the brain. Polyelectrolyte nanogels possess a property which can easily incorporate
oppositely charged low molecular mass drugs or biological macromolecules like phosphorylated nucleoside analogs, siRNA
(for anti-cancer and anti-viral treatment), DNA, proteins, oligonucleotides,
which bind to the nanogel ionic chains and phase
separate within the finite volume of nanogel. Nanogels are also used to deliver molecules like quantum
dots, imaging agents and dyes because of its multiple chemical functionalities
(5) (6) (7).
Nanogels for Anti-inflammatory Drug Delivery in
Skin Diseases:
For effective drug delivery in skin
inflammatory diseases, a skin permeating nanogel
system (SPN) have been developed that is composed of a surface of modified polymeric
bilayered nanoparticles
along with a gelling agent. In this SPN, Poly-(lactide-co-glycolic
acid) and chitosan were used to prepare bilayered nanoparticles (NPS) and
oleic acid (NPSO) was used to make modified surface. For nanogel
formation, hydroxypropyl methyl cellulose (HPMC) and carbopol was used after maintaining the desired viscosity.
These researches have showed the effective percutaneous
delivery of drugs in case of skin diseases (9).
Diclofenac, a non-steroidal
anti-inflammatory drug (NSAID), is mainly used in cases of arthritis. According
to the research evidences, hydrogels of diclofenac sodium liposomal gel have better outcomes as an
anti-inflammatory agent (4).
Nanogels as a Cure for Brain Diseases:
Nanogels have been identified as a successful carrier for oligonucleotides to the brain by using polarized monolayers of bovine BMEC. According to the researches, the
model of blood brain barrier has showed the increased level of oligonucleotides across the cell monolayers
due to the incorporation with nanogels. Nanogels modified with insulin or transferring ligands have
showed the further increased transport of oligonucleotides.
Besides it, these nanogels have showed no adverse or
toxic effects on the model mice (2).
Nanogel Based Drug Delivery in Systemic Lupus Erythematosus:
In case of
systemic lupus erythematous, a novel nanogel vehicle for the delivery of immunosuppressant mycophenolic acid (MPA) was developed. In the model of
lupus-prone mice, the MPA-loaded nanogel was tested
that showed the increased levels of median survival time (MST) by three months
with prophylactic use (MST was 50 weeks versus 38 weeks without treatment with
MPA-loaded nanogel) and by two months after
administration in case of severe renal damage (MST was 12.5 weeks after proteinuria onset versus 4 weeks without treatment). This nanogel treatment resulted in enhancing the biodistribution of drugs to the organ and association with
immune cells (10, 11).
Protein
Nanogels:
Research has reported that hen egg white
proteins ovalbumin and lysozyme
have been prepared as a nanogel. In this novel
method, solution of ovalbumin and lysozyme
with pH 5.3 adjusted upto the pH 10.3 was stirred and
heated. As the nanogels have spherical and core-shell
shape, the core was designed with lysozyme and shell
comprised of ovalbumin. These proteins were in
denatured states, bounded by intermolecular hydrophobic interactions, hydrogen
bonds and disulfide linkages. The charges on nanogels
can be adjusted with the pH of the medium. The surface structure of the nanogel can be stabilized with the help of electrostatic
repulsive force. Alkali has been used in the formation process of these nanogels so that it can be made edible and nutritional.
Besides it, solution of these types of nanogels are
very stable for long time storage and can also be stored as lyophilized powder;
making it more applicable (1).
Benefits
of Nanogel Drug Delivery Approach:
1.
It provides
protection from biodegradation of drugs inside the body.
2.
Physical
properties like size of nanogels can be easily
adjusted and maintained according to the desired delivery molecule.
3.
Low amount drug
is required as well as quantity of doses is reduced.
4.
Improves the
bioavailability of the drug molecule and reduce the toxicity of the drugs.
5.
Drugs loaded nanogels can be delivered inside the body with no adverse
or side effects as well as can be applied topically.
6.
These are able to
cross blood barin barrier as well as physiological
barrier like skin.
Drawbacks
of Nanogels:
1.
It requires expensive
techniques to completely remove the solvent sand surfactants at the end of the
process.
2.
Sometimes, traces
of surfactants can cause toxicity.
CONCLUSION:
Nanogels are effective and novel drug delivery system that has
improved the traditional drug delivery system and appeared to be a best drug
delivery vehicle for various drug biomolecules or
molecules. Future researches can be conducted to study about its improved
designs, targeting properties to enable highly selective uptake into the
desired organs.
REFERENCES:
1. Shaoyong Yu, Ping Yao, Ming Jiang, Guangzhao Zhang (2006). Nanogels Prepared by Self-Assembly of Oppositely Charged Globular Proteins. Biopolymers.
148-158: 83.
2.
Hamsaraj Karanth and Rayasa S. Ramachandra Murthy
(2008). Nanotechnology in Brain
Targeting. International Journal of Pharmaceutical Sciences and
Nanotechnology. 9-24: 1(1).
3.
Koen Raemdonck, Joseph Demeester and Steefan De Smedt (2009). Advanced
Nanogel Engineering for Drug Delivery. Soft
Matter. 707-715: 5.
4.
A. V. Jithan and M. Swathi
(2010). Development of Topical
Diclofenac Sodium Liposomal Gel for Better Anti-inflammatory Activity.
International Journal of Pharmaceutical Sciences and Nanotechnology. 986-993: 3(2).
5.
Serguei V. Vinogradov (2010). Nanogels in the Race for Drug Delivery. Nanomedicine. 165-168:
5(2).
6.
Nilesh Jain, Ruchi Jain, Navneet Thakur, Braham Praksh Gupta, Deepak Kumar Jain, Jeetendra
Banveer, Surendra Jain
(2010). Nanotechnology: A Safe and
Effective Drug Delivery System. Asian Journal of Pharmaceutical and Clinical
Research. 159-165: 3(3).
7.
Alexander V. Kavanob and Serguei
V. Vinogradov (2010). Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities.
National Institute of Health- Public Access.
8.
Dhawal Dorwal (2012). Nanogels as Novel and Versatile Pharmaceuticals.
International Journal of Pharmacy and Pharmaceutical Sciences. 67-74: 4(3).
9.
Punit Shah, Pinaki Desai, Apurva Patel and Mandip Singh
(2012). Skin Permeating Nanogels for the Cutaneous
Co-delivery of Two Anti-inflammatory Drugs. National Institute of Health-
Public Access.
10.
Farhana Sultana, Manirujjaman,
Md. Imran-Ul- Haque, Md.
Arafat, Sanjida Sharmin
(2013). An Overview of Nanogel Drug Delivery System. Journal of Applied
Pharmaceutical Sciences. 95-105: 3(8 Suppl 1).
11.
Michael Look, Eric Stern, Quin A. Wang, Leah
D. DiPlacido, Michael Kashgarian,
Joe Craft and Tarek M. Fahmy
(2013). Nanogel-Based Delivery of Mycophenolic
Acid Ameliorates Systemic Lupus Erthymatosus in Mice.
The Journal of Clinical Insvetigation. 1741-1749: 123(4).
Received on 24.10.2015 Accepted
on 09.11.2015
© Asian Pharma Press All
Right Reserved
Asian J. Res. Pharm. Sci.
5(4): Oct.-Dec. 2015; Page 253-255
DOI: 10.5958/2231-5659.2015.00037.5